Navigation Links
BAXL Technologies Partners With Epikinonia at Maternity Clinic in Athens, Greece
Date:12/19/2007

Combines Internet with VoD for In-Room On-Demand Entertainment and

Education

BETHEL, Conn., Dec. 19 /PRNewswire-FirstCall/ -- BAXL Technologies Inc (OTC Bulletin Board: BXLH), the leading technology solutions provider that enables the transmission of voice, data and video over existing wiring, has partnered with Athens-based Epikinonia Ltd. (EPI) to provide hospital bedside services including high speed Internet access (HSIA) and video on demand (VoD) in-room entertainment at the IASO Clinic located in Athens.

Gus Bottazzi, CEO of BAXL Technologies said, "The IASO Clinic was looking for an advanced technology to improve facility management, add soft-sell advertising revenues, and upgrade the patient experience. BAXL products delivered the perfect infrastructure to layer the initial solution as well as the capacity for the clinic's planned future upgrades of on-site security, maternity web cams and voice over IP. The European healthcare market has always looked to be on the cutting edge and BAXL is facilitating their progression."

The IASO Clinic is one of the largest and most advanced maternity clinics in Europe, with over 13,500 inpatient deliveries annually. It operates one of the most sophisticated Neonatal Intensive Care units in the World, as well as one of the largest cardiotocography units in Europe. Each of the IASO Clinic's 100 rooms will be outfitted with BAXL's HSIA as well as a VoD system. Apart from the obvious in-room entertainment uses, the clinic will also use the system to introduce expecting and new mothers to infant care through a series of videos played over the VoD system.

Partnering with EPI enables BAXL to broaden its reach into the Mediterranean region of Europe. EPI, headquartered in Greece, is a broadband systems integrator servicing the hospitality, health care, government and multi-tenant unit (MTU) / multi-density unit (MDU) markets.

Tasos Moutzouris, Managing
'/>"/>

SOURCE BAXL Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
2. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
3. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
4. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. Advanced technologies aim to transform the coaching of top athletes
7. Global Med Technologies(R) Extends Its Worldwide Outreach
8. Acuo Technologies(R) Names Mike Dolan Vice President of Sales
9. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
10. Neurobiological Technologies Reports Going Concern Qualification
11. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) ... Phase 2b 003-A1 study, known as the 003 ... pre-treated relapsed and refractory multiple myeloma patients. These ... Symposium at the 51st annual meeting of the ... Enrollment in this trial is complete (n=269), and ...
(Date:12/6/2009)... study provides welcome news for patients with a common ... The condition is estimated to impact 62,000 Canadians and ... clot forms in a vein and restricts the flow ... the clot may detach from its point of origin ... a potentially fatal condition known as a pulmonary embolism. ...
(Date:12/6/2009)... of Belluck & Fox, LLP says dangerous substances such as asbestos ... ... New York, NY (PRWEB) December 6, 2009 -- As ... be alert to reports of recalls due to lead paint or ... to 230,000 children visit hospital emergency rooms each year due to ...
(Date:12/5/2009)... Cuts for a Cause ,, Why: ... other terminal illnesses affecting children. All proceeds from each hair ... Hospital. Guests will enjoy complimentary beverages and hors d,oeuvres, provided ... Falls Church for all guests. Hoa Lai, a DJ known ...
(Date:12/5/2009)... Dec. 5 Leukemia and myeloproliferative disorders are ... today at the 51st Annual Meeting of the ... options and improved diagnostic methods for patients suffering ... acute lymphoblastic leukemia, and myelofibrosis that are based ...
Breaking Medicine News(10 mins):Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
... UNICEF have renewed their international partnership for children for another ... on HIV/AIDS 'Unite For Children, Unite Against AIDS'. ... children to enjoy healthy recreation and promote girls' education in ... the agreement. ,UNICEF's regional office for South Asia ...
... body that is responsible for approving NHS treatments has ... blocked the usage of an anti-cancer drug. ... treated with the drug Alimta, whose scientific name ... National Institute for Health and Clinical Excellence (NICE). ...
... Post, the department of health of Washington, D.C.//, on Tuesday is ... between 14years and 84years, to a test, to ... launching of the campaign, to be named “Come Together D.C. ... HIV Testing Day. ,Gregg Pane, the director of the. ...
... It has been reported that towards the end of last ... transplant//. ,Surgeons at Sydney's Royal Prince Alfred Hospital ... Myles of Cowra in central-eastern New South Wales. Leanne Myles ... failure of her liver, kidneys, and pancreas. ,She ...
... Mice lacking a gene for normal immune functioning found ... attacks //liver and spleen - a new study finds. ... a pathogen called Leishmania donovani, affects certain internal organs. ... quite often affected by this infectious disease through the ...
... department today advised people to take precautionary measures in view ... and jaundice during summer. // ,The people have ... minutes and wash raw vegetables and fruit thoroughly before eating, ... has also advised people to wash hands with soap after ...
Other Medicine News:Health News:Lack of STAT1 -an Immune Protein, Pack Liver Infection Cure 2Health News:Lack of STAT1 -an Immune Protein, Pack Liver Infection Cure 3
(Date:12/4/2009)... Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: ... successful testing of a novel integrated light source architecture ... engine design raises the bar on imaging speed and ... OCT light sources. This approach to optical engines ...
(Date:12/4/2009)... Neal Shore and E. David Crawford presented results for ... secondary end points of biochemical recurrence rate in a ... injection) or monthly leuprolide in prostate cancer patients during ... who received FIRMAGON 240/80 mg/month had a recurrence rate ...
(Date:12/3/2009)... NEW YORK, Dec. 3 Guidepoint Global, LLC , ... their Sleep Apnea Tracker, a monthly longitudinal data release that ... Sleep Apnea market. ,, The Sleep Apnea Tracker captures ... sold in the United States from 15 different equipment providers ...
Breaking Medicine Technology:Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 1ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 2ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 3ZyGEM Releases Data Confirming Its prepGEM 28R 29 Bacteria Kit Is a Simple Universal Method for Extracting DNA from Different Bacteria Species 51198 4Life Spine 28R 29 Announces FDA Clearance of FS3 28TM 29 Minimally Invasive Spinal System 51196 1Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat P 12956 1Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat P 12956 2Harvest Technologies Announces Completion of Patient Enrollment in its 60 Patient Clinical Trial in India Using Autologous Adult Stem Cells to Treat P 12956 3
... medical and economic advantages of nifedipine,GITS therapy ... 28, 2007 – Two recently,published articles in ... that the use of the long-acting calcium ... additional,benefits beyond its blood pressure lowing effect. ...
... shows orally-delivered GLP-1 is able to stimulate ... --,Emisphere Technologies, Inc. reported today results of ... Christoph,Beglinger, M.D. Division of Gastroenterology and Hepatology,University ... of,the study with glucagon-like peptide-1 (7-36 amide) ...
Other Medicine Technology:Calcium Channel Blocker Adalat GITS Offer Additional Benefits 2Calcium Channel Blocker Adalat GITS Offer Additional Benefits 3Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 2Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 3Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 4Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery,of GLP-1 and PYY 5
Silicone Foley Catheters 3-Way...
Midstream Catch Kits...
... Pediatric BladderScan® is the ... Ultrasound's trusted family of ... healthcare providers to measure ... noninvasively, this easy-to-use, handheld ...
... BladderScan BVM 6500 enables ... to determine UEBW (ultrasound ... bladder volume using 3-dimensional ... 6500 was designed to ...
Medicine Products: